174 related articles for article (PubMed ID: 22004550)
1. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.
Sridhar J; Foroozesh M; Stevens CL
SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550
[TBL] [Abstract][Full Text] [Related]
2. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors.
Jiang YR; Yang YY; Chen YL; Liang ZJ
Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934
[TBL] [Abstract][Full Text] [Related]
3. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
[TBL] [Abstract][Full Text] [Related]
4. Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1 inhibitors.
Zhang S; Lin Z; Pu Y; Zhang Y; Zhang L; Zuo Z
Comput Biol Chem; 2017 Apr; 67():38-47. PubMed ID: 28043074
[TBL] [Abstract][Full Text] [Related]
5. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
6. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
[TBL] [Abstract][Full Text] [Related]
7. Comparative QSAR studies on peptide deformylase inhibitors.
Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
[TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
Mondal C; Halder AK; Adhikari N; Jha T
Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
[TBL] [Abstract][Full Text] [Related]
9. QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
Garcia ML; de Oliveira AA; Bueno RV; Nogueira VHR; de Souza GE; Guido RVC
Drug Dev Res; 2022 Apr; 83(2):264-284. PubMed ID: 32045013
[TBL] [Abstract][Full Text] [Related]
10. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
11. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
12. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
Korhonen LE; Rahnasto M; Mähönen NJ; Wittekindt C; Poso A; Juvonen RO; Raunio H
J Med Chem; 2005 Jun; 48(11):3808-15. PubMed ID: 15916432
[TBL] [Abstract][Full Text] [Related]
13. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
Gaurav A; Singh R
Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
[TBL] [Abstract][Full Text] [Related]
14. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
[TBL] [Abstract][Full Text] [Related]
15. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies.
Sharma MC; Jain S; Sharma R
In Silico Pharmacol; 2017; 5():13. PubMed ID: 29098139
[TBL] [Abstract][Full Text] [Related]
16. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of quantitative structure activity relationship methods based on antitumor diarylsulfonylureas.
Park Choo HY; Lim JS; Kam Y; Kim SY; Lee J
Eur J Med Chem; 2001 Oct; 36(10):829-36. PubMed ID: 11738489
[TBL] [Abstract][Full Text] [Related]
19. In silico QSAR studies of anilinoquinolines as EGFR inhibitors.
Pasha FA; Muddassar M; Srivastava AK; Cho SJ
J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909
[TBL] [Abstract][Full Text] [Related]
20. Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors.
Castilho MS; Postigo MP; de Paula CB; Montanari CA; Oliva G; Andricopulo AD
Bioorg Med Chem; 2006 Jan; 14(2):516-27. PubMed ID: 16203153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
